Compare iShares MSCI India ETF (INDA) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI India ETF vs Smith & Nephew plc — how do they compare? iShares MSCI India ETF trades at $48.2, while Smith & Nephew plc trades at $29.95 (market cap $12.71B). The key difference: Smith & Nephew plc pays a 2.59% dividend while iShares MSCI India ETF pays none, and iShares MSCI India ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| INDA | SNN | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $55.29 | $38.70 |
52-Week Low | $45.42 | $28.73 |
Market Cap | — | $12.71B |
Enterprise Value | — | $15.48B |
Dividend Yield | — | 2.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INDA, the iShares MSCI India ETF, trades at $48.56, down 0.72% on the day. The technical outlook is bearish, with moving averages indicating selling pressure and oscillators neutral. Recent news highlights India's strong economic growth at 7.8% for Q1 2026 (CNBC, 2026-06-05) but notes headwinds including muted IT sector performance and geopolitical risks from the Middle East.
The ETF offers exposure to India's fast-growing economy but faces near-term risks from sector-specific challenges and external volatility. Analyst sentiment is mixed, with some seeing value in the long-term growth story despite recent underperformance versus other emerging markets.
SNN trades at $30.21, down 1.24% today, with a bearish technical signal and mixed earnings history. Revenue grew to $5.81B in 2024 with net income of $412M, while valuation ratios like P/E of 21.25 and P/S of 2.15 suggest moderate pricing. Recent news highlights product launches in robotics and wound care, supporting growth initiatives.
Outlook is cautiously optimistic with strong cash flow and analyst buy ratings at 27%, but risks include earnings misses and rising debt. The stock offers potential from operational improvements, though investor sentiment remains divided amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
